Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model
B. Danysh, E. Rieger, Deepankar Sinha, Caitlin Evers +3 more
2016OncoTarget65 citations Open access
Semantic Scholar

